Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Vascular · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Summary of findings: Intravenous prostacyclin analogue (iloprost) vs intravenous prostaglandin analogue

Ulcer healing · patients with Buerger's disease

It is very uncertain whether intravenous prostacyclin analogue changes ulcer healing compared with intravenous prostaglandin analogue (very low certainty).

1 finding from 1 review

Pharmacological treatment for Buerger's disease 2020 · Cochrane Headline outcomes only
RR 1.13 [0.76, 1.69]
2 studies · 89 participants
Very low

Summary of findings: Intravenous prostacyclin analogue (iloprost) vs intravenous prostaglandin analogue

Complete relief of pain · patients with Buerger's disease

Intravenous prostacyclin analogue showed no clear difference in complete relief of pain compared with intravenous prostaglandin analogue (low certainty).

1 finding from 1 review

Pharmacological treatment for Buerger's disease 2020 · Cochrane Headline outcomes only
RR 1.57 [0.72, 3.44]
1 study · 38 participants
Low

Summary of findings: Intravenous prostacyclin analogue (iloprost) vs intravenous prostaglandin analogue

Rate of amputation · patients with Buerger's disease

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for Buerger's disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found